| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2901e694724c2a759f619944cb7d2a4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02 |
| filingDate |
2004-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86cbb300ce600d88a322eff6b183bf4b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b16e2dc3616df030ce48a171d0c6c3dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8512af55723c053e4db60b72b85495d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7963a2e88f9cdcd48c2d17f56601ba0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a16d0510e4b35e0bf040814ae6e48d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1494f78e530cf84332e9d831c63d16f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9424eee43f8075bacd085b3efac8c453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f909ad95eb7c38bb9f09762e7054d7b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95f44ac85c5d2febc76819a4340f9bb6 |
| publicationDate |
2005-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005070575-A1 |
| titleOfInvention |
Chemical derivatives and their application as antitelomerase agents |
| abstract |
The present invention relates to cancer therapy and to novel anticancer agents having a mechanism of action which inhibits telomerase. It also relates to novel chemical compounds as well as their therapeutic application in humans. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9572891-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9072790-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7563618-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010016416-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008119492-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8440635-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003138814-A1 |
| priorityDate |
2001-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |